A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib

Dasatinib is a second-generation tyrosine kinase inhibitor with activity on the BCR-ABL fusion gene. It is used in the treatment of BCR-ABL positive chronic myeloid leukaemia and has the known side effect of pleural effusion. This usually involves exudate with the presence of lymphocytes. A more unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradt, Nicolas, Olbrechts, Frederic, Alexander, Patrick, Salembier, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678124/
https://www.ncbi.nlm.nih.gov/pubmed/36415836
http://dx.doi.org/10.12890/2022_003601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678124/
https://www.ncbi.nlm.nih.gov/pubmed/36415836
http://dx.doi.org/10.12890/2022_003601

Ejemplares similares